NCI Participation in PA-18-141, Mechanisms, Models, Measurement, & Management in Pain Research (R01 Clinical Trial Optional)

Notice Number: NOT-CA-18-068

Key Dates
Release Date: April 19, 2018

Related Announcements
PA-18-141

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) is participating in PA-18-141, "Mechanisms, Models, Measurement, & Management in Pain Research (R01 Clinical Trial Optional)."
 
The following change has been made to reflect NCI's participation in this FOA:
 
Part 1. Overview Information
 
Components of Participating Organizations
National Institute of Nursing Research (NINR)
National Institute on Aging (NIA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Neurological Disorders and Stroke (NINDS)
National Center for Complementary and Integrative Health (NCCIH)
National Institute on Minority Health and Health Disparities (NIMHD)
National Cancer Institute (NCI)
 

There is no change to CFDA numbers, which already reflect NCI's involvement.
All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Ann O'Mara, Ph.D., R.N.
National Cancer Institute (NCI)
Telephone: 240-276-7050 
Email: omaraa@mail.nih.gov